Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8852983.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with acute lymphocytic leukemia and multidrug-resistant tuberculosis of the brain and spinal cord. Despite treatment with six antituberculous drugs and a steroid medication for 11 months, there was no appreciable clinical or radiological improvement in the patient's condition. Within 5 months of initiating adjunctive therapy with IFN-gamma and granulocyte colony stimulating factors, substantial neurological and radiological improvement was noted. Therapy with IFN-gamma was continued for 12 months, resulting in complete resolution of the lesions in the brain and spinal cord.
Medical subject headings
- Antitubercular Agents
- Brain
- Granulocyte Colony-Stimulating Factor
- Immunocompromised Host
- Interferon-gamma
- Mycobacterium tuberculosis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Tuberculosis, Multidrug-Resistant